Rocket Pharmaceuticals Inc. (RCKT)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 2 |
| Ownership rank: | 361 |
| % of all portfolios: | 0.029% |
| Hold Price * : | $26.94 |
| History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
| Q1 2024 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 3.61% | 145,756 | 0.08 | |
| Q4 2023 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 28.35% | 1,595,902 | 0.99 | |
| Q2 2023 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 0.63% | 27,653 | 0.01 | |
| Q1 2023 | |||||
| ≡ | Torray Funds | Reduce 0.17% | 92 | 0.00 | |
| Q4 2022 | |||||
| ≡ | Torray Funds | Reduce 4.61% | 2,627 | 0.01 | |
| Q3 2022 | |||||
| ≡ | Torray Funds | Reduce 5.83% | 3,524 | 0.01 | |
| Q4 2021 | |||||
| ≡ | Torray Funds | Reduce 3.53% | 1,333 | 0.00 | |
| Q1 2021 | |||||
| ≡ | Torray Funds | Reduce 15.68% | 5,403 | 0.04 | |
| Q4 2020 | |||||
| ≡ | Torray Funds | Reduce 29.37% | 14,331 | 0.13 | |
| Q2 2020 | |||||
| ≡ | Torray Funds | Reduce 13.96% | 7,881 | 0.03 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.